Orencia (Abatacept) 250mg/Vial (IV)

$1,500.00

Drug Info: ApoThera Drug Disease Clinical Support App

Psoriatic Arthritis (IV Dose)
– Dosing is according to body weight
– Initial IV infusion (weight-based dosing)
THEN,
– Repeat IV infusion (the same weight-based dosing) at 2 weeks and 4 weeks after the initial infusion
THEN,
– Every 4 weeks thereafter.
– <60 kg: 500 mg
– 60 to 100 kg: 750 mg
– >100 kg: 1,000 mg
Rheumatoid Arthritis (IV Dose)
– Dosing is according to body weight
– Initial IV infusion (weight-based dosing)
THEN,
– Repeat IV infusion (the same weight-based dosing) at 2 weeks and 4 weeks after the initial infusion
THEN,
– Every 4 weeks thereafter.
– <60 kg: 500 mg
Manufacturer: Bristol Myers Squibb
NDC: 00003-2187-13 Category:

1 Vial = 1 Unit

Description

IV Administration
– Infuse over 30 minutes
– Administer through a 0.2 to 1.2 micron low protein-binding filter
Storage
Intact Vial
– Store at 2°C to 8°C (36°F to 46°F)
– Do not freeze
– Protect from light
After Dilution
–  In NS, may be stored for up to 24 hours at room temperature or refrigerated at 2°C to 8°C (36°F to 46°F).
– Must be used within 24 hours of reconstitution
Monitoring
–  Signs and symptoms of infection
– Signs and symptoms of hypersensitivity reaction
– Hepatitis and TB screening prior to therapy initiation
Tags: , , , , , , , , , , , , , , , , , ,

Related Products